MODERN INNOVATIVE APPROACHES IN DERMATOVENEREOLOGY: TELEDERMATOLOGY, MOLECULAR DIAGNOSTICS, AND NOVEL THERAPEUTIC STRATEGIES
- Authors
-
-
Allaeva M. D.
Associate Professor, Department of Therapeutic Disciplines, Kimyo International University in Tashkent, Uzbekistan
Author
-
Khudayarova D.
4th-year Student, Faculty of General Medicine, Kimyo International University in Tashkent, Uzbekistan
Author
-
Allaeva K. B.
Master’s Student, Department of Public Health, Westminster International University in Tashkent
Author
-
- Keywords:
- Teledermatology, molecular diagnostics, innovative therapeutic approaches, dermatovenereology, personalized medicine.
- Abstract
-
This article presents an in-depth analysis of modern innovative directions in dermatovenereology, with a focus on teledermatology, molecular genetic and epigenetic diagnostics, as well as novel therapeutic strategies. Based on data from international and domestic studies from 2020–2025, it is demonstrated that the integration of digital technologies, high-precision molecular methods, and targeted therapy is forming a new paradigm of personalized dermatological care. Clinical, organizational, and prognostic aspects of implementing these approaches are discussed.
- References
-
1.Ferrándiz L, Carrascosa JM, Dalmau J. Teledermatology: Past, present, and future. Actas Dermosifiliogr. 2020;111(4):329–339. doi:10.1016/j.ad.2019.10.003.
2.Menzies S, Bingham LJ, Hains I. Teledermatology in Australia: Adoption and patterns of use among dermatologists. Australas J Dermatol. 2022;63(2):e215–e222. doi:10.1111/ajd.13752.
3.Perkins S, Davis SA, González M. Patient satisfaction with teledermatology during the COVID-19 pandemic. J Telemed Telecare. 2021;27(10):615–621. doi:10.1177/1357633X20984341.
4.Wallace DL, Cruz PD. Mobile teledermatology and teledermatoscopy: Expanding access to dermatologic care. Dermatol Clin. 2021;39(4):543–555. doi:10.1016/j.det.2021.05.002.
5.Lobanov AN, Kruglova LS. Teledermatology: Opportunities and prospects for clinical practice. Vestnik Dermatologii i Venerologii. 2020;96(4):7–14.6.Kruglova LS, Namazova-Baranova LS, Lobanov AN. Telemedicine in dermatology: Experience in the Russian Federation. Prakticheskaya Meditsina. 2021;19(2):45–51.
7.Smith FJD, McLean WHI. Advances in genetic diagnosis of inherited skin diseases with next-generation sequencing. J Invest Dermatol. 2020;140(6):1077–1084. doi:10.1016/j.jid.2019.12.026.
8.Johnson B, Tsoi LC, Gudjonsson JE. Genomic insights into ichthyosis and epidermolysis bullosa. Br J Dermatol. 2019;180(5):1030–1044. doi:10.1111/bjd.17361.
9.Lee CS, Bae JM, Cho S. Genomic characterization of cutaneous squamous cell carcinoma: Current knowledge and clinical implications. Front Med. 2021;8:678. doi:10.3389/fmed.2021.652914.
10.Wang SQ, Setlow RB, Berwick M. BRAF mutations and targeted therapy in melanoma: Clinical applications. N Engl J Med. 2020;382:1930–1941. doi:10.1056/NEJMra1903726.
11.Garcia R, Navarrete-Dechent C. Next-generation sequencing in cutaneous T-cell lymphoma: Diagnostic value and challenges. J Am Acad Dermatol. 2021;85(4):1045–1053. doi:10.1016/j.jaad.2020.12.073.
12.Lenardis MA, Solomon RS, Leung FH. Diagnostic performance of PCR-based testing in dermatophytosis: A large-scale evaluation. Mycoses. 2023;66(4):345–355. doi:10.1111/myc.13541.
- Downloads
- Published
- 2026-04-07
- Issue
- Vol. 2 No. 4 (2026)
- Section
- Articles
- License
-
This work is licensed under a Creative Commons Attribution 4.0 International License.
